Effectiveness and safety of tocilizumab combined with different high‐dose methylprednisolone regimens for acute necrotizing encephalopathy in children

Documenti analoghi

• Current situation and prospect for the diagnosis and treatment of pediatric critical rare diseases in China
  di: Yingchao Liu, et al.
  Pubblicazione: (2024)
• Prevalence of non‐alcoholic fatty liver disease and its association with different combinations of weight status and metabolic abnormalities in children aged 6–18 years
  di: Peiyu Ye, et al.
  Pubblicazione: (2026)
• Effectiveness and safety of perampanel for pediatric patients with epilepsy: A real‐world study from China
  di: Xiaohui Wang, et al.
  Pubblicazione: (2025)
• Microbiota diversity and differences in the respiratory tract of children with pneumonia
  di: Dandan Ge, et al.
  Pubblicazione: (2025)
• Predicting brain age in children aged 2–6 years with autism spectrum disorders using routine T1‐ and T2‐weighted magnetic resonance imaging
  di: Zunying Hu, et al.
  Pubblicazione: (2026)